Founder, President and Chief Executive Officer of New Promise Neuropathy
Dr. Alavi possesses extensive medical experience in General Primary Care, Cardiology, Hospital Medicine, including ICU and Critical Care, and Hospice and Palliative Care. He now focuses on treating Peripheral Neuropathy and holds the positions of Founder, President, and Chief Executive Officer at New Promise Neuropathy. In this capacity, he utilizes The Combined Electro-Analgesia Treatment among other non-invasive therapeutic modalities to manage this challenging condition.
Dr. Alavi obtained his Bachelor of Science Degree in Cell and Molecular Biology and Chemistry from the University of Nevada Las Vegas and holds postgraduate degrees in Microbiology and Virology.
He continued his education at Touro University College of Osteopathic Medicine in California, followed by a Cardiology Track-Internal Medicine residency at the University of North Texas Health Science Center in Fort Worth.
Beyond his clinical practice, Dr. Alavi participates in clinical trials focusing on Peripheral Neuropathy and serves as an advisor to diverse research, educational, and charitable institutions. He advocates for Evidence-Based Medicine and a holistic, patient-centered approach to care, underlining his deep commitment to his patients.
Outside his professional commitments, Dr. Alavi engages in travel, reading, and humanitarian projects, working alongside organizations, churches, and charitable foundations to support those in need.